arrow_back Back to App

Support for Myotonic Dystrophy Awareness Day, boosting research and aid.

The U.S. Senate expresses support for designating September 15 as International Myotonic Dystrophy Awareness Day. The aim is to raise awareness of this rare disease, support research for treatments, and improve the quality of life for affected individuals and their caregivers. Citizens can expect increased public awareness and potentially better access to support.
Key points
Designation of September 15 as International Myotonic Dystrophy Awareness Day.
Support for scientific research and innovation in finding treatments for myotonic dystrophy.
Promotion of programs and policies assisting individuals with myotonic dystrophy and their caregivers.
Encouraging awareness and education about myotonic dystrophy for patients, caregivers, and clinicians.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 117_SRES_772
Sponsor: Sen. Kaine, Tim [D-VA]
Process start date: 2022-09-19
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution recognizing the seriousness of myotonic dystrophy and expressing support for the designation of September 15, 2022, as "International Myotonic Dystrophy Awareness Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_SRES_772.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-09-19.

What are the main provisions?

Key points include:

  • Designation of September 15 as International Myotonic Dystrophy Awareness Day.
  • Support for scientific research and innovation in finding treatments for myotonic dystrophy.
  • Promotion of programs and policies assisting individuals with myotonic dystrophy and their caregivers.
  • Encouraging awareness and education about myotonic dystrophy for patients, caregivers, and clinicians.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Kaine, Tim [D-VA].

What is the latest detailed status?

The latest detailed status is: Resolution agreed to in Senate without amendment and with a preamble by Unanimous Consent.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health